Interferon lambda: opportunities, risks and uncertainties in the fight against HCV

by Stephen M Laidlaw, Lynn B Dustin
Published 2014-10-01

Recent Advances in HBV and HCV Immunology

by Lynn B Dustin, Nirupma eTrehanpati
Published 2015-09-01

TRIM21/Ro52 - Roles in Innate Immunity and Autoimmune Disease

by Esther L. Jones, Stephen M. Laidlaw, Lynn B. Dustin
Published 2021-09-01

The humoral immune response to HCV: understanding is key to vaccine development

by Siobhán B Cashman, Brian D. Marsden, Brian D. Marsden, Lynn B Dustin
Published 2014-11-01

Selection of apoptotic cell specific human antibodies from adult bone marrow.

by Caroline Grönwall, Edgar D Charles, Lynn B Dustin, Christoph Rader, Gregg J Silverman
Published 2014-01-01

MAIT cells are activated during human viral infections

by Bonnie van Wilgenburg, Iris Scherwitzl, Edward C. Hutchinson, Tianqi Leng, Ayako Kurioka, Corinna Kulicke, Catherine de Lara, Suzanne Cole, Sirijitt Vasanawathana, Wannee Limpitikul, Prida Malasit, Duncan Young, Laura Denney, STOP-HCV consortium, Michael D. Moore, Paolo Fabris, Maria Teresa Giordani, Ye Htun Oo, Stephen M. Laidlaw, Lynn B. Dustin, Ling-Pei Ho, Fiona M. Thompson, Narayan Ramamurthy, Juthathip Mongkolsapaya, Christian B. Willberg, Gavin R. Screaton, Paul Klenerman
Published 2016-06-01